BR112017013277A2 - composição aquosa, método de amplificação isotérmica de ácido nucleico e kit - Google Patents

composição aquosa, método de amplificação isotérmica de ácido nucleico e kit

Info

Publication number
BR112017013277A2
BR112017013277A2 BR112017013277A BR112017013277A BR112017013277A2 BR 112017013277 A2 BR112017013277 A2 BR 112017013277A2 BR 112017013277 A BR112017013277 A BR 112017013277A BR 112017013277 A BR112017013277 A BR 112017013277A BR 112017013277 A2 BR112017013277 A2 BR 112017013277A2
Authority
BR
Brazil
Prior art keywords
nucleic acid
acid amplification
composition
affinity constant
kit
Prior art date
Application number
BR112017013277A
Other languages
English (en)
Other versions
BR112017013277B1 (pt
Inventor
W Sitton Gregory
Percy Neil
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of BR112017013277A2 publication Critical patent/BR112017013277A2/pt
Publication of BR112017013277B1 publication Critical patent/BR112017013277B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/125Specific component of sample, medium or buffer

Abstract

a presente invenção refere-se a uma composição para reduzir os efeitos inibitórios de contaminantes sobre a amplificação de ácido nucleico. a composição inclui quantidades eficazes de ferro férrico, um reagente orgânico quelante de ferro, e um tensoativo não iônico. opcionalmente, a composição inclui polivinilpirrolidona. a composição tem um ph de cerca de 8,45 a 8,85. o reagente orgânico quelante de ferro tem uma primeira constante de afinidade maior ou igual a 104,2, com relação ao ferro férrico, e uma segunda constante de afinidade menor que 103,8, com relação ao magnésio. a primeira constante de afinidade e a segunda constante de afinidade são determinadas em água deionizada em ph 8,45 e a 20°c. também são fornecidos métodos de uso da composição para preparar uma amostra para a amplificação de ácido nucleico.
BR112017013277-0A 2014-12-23 2015-12-21 Composição aquosa e método de amplificação isotérmicade ácido nucleico BR112017013277B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462096217P 2014-12-23 2014-12-23
US62/096,217 2014-12-23
US201562136682P 2015-03-23 2015-03-23
US62/136,682 2015-03-23
PCT/US2015/066968 WO2016106166A1 (en) 2014-12-23 2015-12-21 Composition for reducing inhibition of nucleic acid amplification

Publications (2)

Publication Number Publication Date
BR112017013277A2 true BR112017013277A2 (pt) 2018-02-27
BR112017013277B1 BR112017013277B1 (pt) 2023-02-23

Family

ID=55229838

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013277-0A BR112017013277B1 (pt) 2014-12-23 2015-12-21 Composição aquosa e método de amplificação isotérmicade ácido nucleico

Country Status (7)

Country Link
US (1) US10604787B2 (pt)
EP (2) EP3594342B1 (pt)
JP (1) JP6650944B2 (pt)
KR (1) KR102603420B1 (pt)
CN (1) CN107109402B (pt)
BR (1) BR112017013277B1 (pt)
WO (1) WO2016106166A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10604787B2 (en) 2014-12-23 2020-03-31 3M Innovative Properties Company Composition for reducing inhibition of nucleic acid amplification
US11168352B2 (en) 2016-04-08 2021-11-09 3M Innovative Properties Company Process for cell lysis and nucleic acid amplification
SG10201800316RA (en) * 2018-01-12 2019-08-27 Delta Electronics Int’L Singapore Pte Ltd Additive composition used in lamp reaction
EP3810791A1 (en) * 2018-06-20 2021-04-28 3M Innovative Properties Company Enrichment supplement for antimicrobal matrices
US11851702B2 (en) * 2020-03-23 2023-12-26 The Broad Institute, Inc. Rapid diagnostics
GB202020576D0 (en) * 2020-12-24 2021-02-10 Univ Dundee Method of eluting nucleic acid
GB2607391A (en) * 2021-03-10 2022-12-07 Phoenix Dx Ltd Nucleic acid amplification, kits, methods, and uses
WO2023031691A1 (en) * 2021-09-01 2023-03-09 3M Innovative Properties Company Compositions and methods of detecting analytes
EP4163369A1 (en) * 2021-10-08 2023-04-12 AXAGARIUS GmbH & Co. KG Use of mixtures of polyvinylpyrrolidone and ammonium sulfate in the isolation of nucleic acids

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS506607B2 (pt) 1971-08-26 1975-03-15
JP3062250B2 (ja) * 1994-03-10 2000-07-10 ジェン−プローブ・インコーポレイテッド イオン性界面活性剤による、酵素により媒介される反応に対する阻害の抑制方法
US5712095A (en) 1994-06-16 1998-01-27 Becton Dickinson And Company Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probes specific for ribosomal RNA precursors
JPH08149974A (ja) 1994-11-30 1996-06-11 Q P Corp Pcr用増菌培地
US5620869A (en) 1995-09-28 1997-04-15 Becton, Dickinson And Company Methods for reducing inhibition of nucleic acid amplification reactions
CA2255624C (en) 1996-05-22 2007-09-04 Gen-Probe Incorporated Compositions and methods for the detection of mycobacterium kansasii
US6210881B1 (en) * 1996-12-30 2001-04-03 Becton, Dickinson And Company Method for reducing inhibitors of nucleic acid hybridization
US9481912B2 (en) * 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
JP5006607B2 (ja) 2006-09-19 2012-08-22 栄研化学株式会社 核酸増幅反応における阻害を回避する方法
KR101039521B1 (ko) * 2008-02-01 2011-06-08 주식회사 인트론바이오테크놀로지 금속 이온에 의해 발생하는 pcr 저해 및 비특이 증폭을완화시키거나 막을 수 있는 에틸렌글리콜테트라아세틱 산을킬레이트제로 포함하는 pcr 반응용 조성물
JP2011097828A (ja) * 2008-07-09 2011-05-19 Beckman Coulter Inc 全血試料の前処理方法及び核酸増幅方法
WO2012108471A1 (ja) * 2011-02-10 2012-08-16 Biocosm株式会社 核酸抽出液の製造方法
CN104471074A (zh) * 2012-03-28 2015-03-25 长角牛疫苗和诊断有限责任公司 用于从生物样品中采集和分离核酸的组合物和方法
US20150225712A1 (en) 2012-08-21 2015-08-13 Qiagen Gmbh Method for isolating nucleic acids from a formaldehyde releaser stabilized sample
EP2730653A1 (en) * 2012-11-07 2014-05-14 QIAGEN GmbH Method for lysing a fixed biological sample
CN107002129A (zh) 2014-09-02 2017-08-01 菲尔莫兹姆公司 基因检测平台
US10604787B2 (en) 2014-12-23 2020-03-31 3M Innovative Properties Company Composition for reducing inhibition of nucleic acid amplification
BR112017024191B1 (pt) * 2015-05-11 2024-01-02 3M Innovative Properties Company Composição aquosa, método de amplificação de ácido nucleico e kit

Also Published As

Publication number Publication date
EP3594342B1 (en) 2021-11-03
US10604787B2 (en) 2020-03-31
JP2018500033A (ja) 2018-01-11
EP3237637A1 (en) 2017-11-01
BR112017013277B1 (pt) 2023-02-23
US20170369929A1 (en) 2017-12-28
CN107109402A (zh) 2017-08-29
WO2016106166A1 (en) 2016-06-30
EP3237637B1 (en) 2019-09-04
CN107109402B (zh) 2020-09-25
KR20170092697A (ko) 2017-08-11
JP6650944B2 (ja) 2020-02-19
KR102603420B1 (ko) 2023-11-16
EP3594342A1 (en) 2020-01-15

Similar Documents

Publication Publication Date Title
BR112017013277A2 (pt) composição aquosa, método de amplificação isotérmica de ácido nucleico e kit
BR112017024191A2 (pt) composição aquosa, método de amplificação de ácido nucleico e kit
MX2020003996A (es) Solucion de conservacion de acido nucleico y metodos de elaboracion y uso.
BR112017025813A2 (pt) método, kit ou composição, micróbio comensal benéfico, método para tratar ou prevenir o câncer e formulação bacteriana
EP4257596A3 (en) Coumarin compounds and their uses as fluorescent labels
SA521421271B1 (ar) تركيبة وطريقة لثبات الأحماض النووية في عينات بيولوجية
WO2016130704A3 (en) Methods and compositions for analyzing cellular components
IN2015DN02793A (pt)
BR112018010341A2 (pt) composição, sistema e método para tratamento do cabelo, método para alteração da cor do cabelo, e, kit de multicompartimentos para alteração da cor ou do formato do cabelo.
SG10201907142VA (en) Etching composition
MX2019005199A (es) Métodos para evaluar el riesgo usando and libre de células total y específico.
MX2016016898A (es) Metodos y composiciones para analisis de muestras.
WO2015195949A3 (en) Methods, compositions, and devices for rapid analysis of biological markers
CO2018011856A2 (es) Composiciones, métodos y kits para la síntesis y detección de ácidos nucleicos
SG10201806000YA (en) Primer set for pcr for bacterial dna amplification, kit for detection and/or identification of bacterial species, and, method of detection and/or identification of bacterial species
BR112017009028A2 (pt) métodos e sistema para suprimir corrosão em superfícies de metal.
BR112017009339A2 (pt) método e sistema
CL2017002111A1 (es) Composición ácida a base de leonardita y aminoácidos
MX2018015439A (es) Conservacion de microorganismos.
BR112012023875A2 (pt) uso de acromopeptidase para lise em temperatura ambiente
WO2018080225A3 (ko) 시식성 파리의 종 구별용 snp 마커 및 이의 용도
CA3010199A1 (en) Method of direct target sequencing using nuclease protection
BR112015019200A2 (pt) método para remover ferro de um banho de pré-tratamento
WO2018128706A3 (en) Modified nucleic acids for nanopore analysis
MX2017003473A (es) Amplificacion hibrida de acido nucleico en multiples pasos.

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2015, OBSERVADAS AS CONDICOES LEGAIS